期刊文献+

铝碳酸镁联合维生素B6治疗妊娠剧吐的疗效和安全性评价 被引量:6

The Efficacy and Safety Evaluation of Hydrotalcite Combined with Vitamin B6 in Treatment of Hyperemesis Gravidarum
下载PDF
导出
摘要 目的:探讨铝碳酸镁联合维生素B6治疗妊娠剧吐的临床疗效和安全性。方法:101例妊娠剧吐患者按治疗方案分为2组。对照组给予维生素B6和静脉补液,治疗组在对照组的基础上嚼服铝碳酸镁,比较2组疗效、不良反应和妊娠结局。结果:治疗组患者治疗有效(95. 24%),高于对照组患者(84. 75%),差异有统计学意义(P <0. 05)。治疗组患者呕吐症状消失时间、酮体转阴时间、电解质恢复正常时间、输液时间均短于对照组,用药后妊娠呕吐评分低于对照组,差异有统计学意义(P <0. 05)。2组患者不良反应发生情况和妊娠结局差异无统计学意义(P> 0. 05)。结论:铝碳酸镁联合维生素B6治疗妊娠剧吐效果显著,妊娠期使用相对安全,值得临床推广。 [Objective] To investigate the therapeutic effect and safety evaluation of hydrotalcite combined with vitamin B6 on hyperemesis gravidarum. [Method] 101 hyperemesis gravidarum patients w ere divided into control group and treatment group according to the treatment plan. The control group w as given vitamin B6 w ith venous rehydration,and the treatment group w as chew ed Hydrotalcite tablets on the basis of the control group. The efficacy,adverse reactions and pregnancy outcome of the tw o groups w ere compared. [Result] The effective rate in the treatment group( 95.24%) w as higher than that in the control group( 84. 75%),and the difference w as statistically significant( P〈0. 05).In treatment group,time of vomiting symptoms disappeared. Ketone body transition,electrolyte returned to normal and infusion duration w as shorter than that of the control group. The average vomiting score after treatment w as less than that of the control group. All the above difference w as statistically significant( P〈0. 05). [Conclusion] Oral hydrotalcite combined w ith vitamin B6 in the treatment of hyperemesis gravidarum patients w ith significant effect. It is relatively safe and w orthy of promotion.
作者 苏倩 方国英 SU Qian;FANG Guoying(Hangzhou Women s Hospital,Hangzhou 310008,China)
出处 《浙江医学教育》 2018年第5期46-48,共3页 Zhejiang Medical Education
关键词 铝碳酸镁 妊娠剧吐 疗效 安全性 Hydrotalcite hyperemesis gravidarum therapeutic effect safety
  • 相关文献

参考文献5

二级参考文献50

  • 1张秀英,欧阳云帆.重视孕期用药安全 掌握孕期用药原则[J].中国实用医药,2007,2(33):125-126. 被引量:4
  • 2宋薇薇,张世妹,尚涛,李和泉.妊娠剧吐 208例临床分析[J].中华妇产科杂志,2006,41(2):128-129. 被引量:69
  • 3谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 4American College of Obstetrics and Gynecology. ACOG Practice Bulletin: nausea and vomiting of pregnancy[J]. Obstet Gynecol,2015,126 ( 3 ) : e 12-e24.
  • 5Niebyl JR. C|inical practice. Nausea and vomiting in pregnancy[J]. N Engl J Med, 2010, 363(16): 1544-1550.
  • 6Goodwin TM. Hyperemesis gravidarum[J]. Obstet Gyneeol Clin North Am, 2008, 35(3):401-417.
  • 7Tamay AG, Ku~qu NK. Hyperemesis gravidarum: Current aspect[J]. J Obstet Gyneeol, 2011, 31 (8):708-712.
  • 8Bottomley C, Bourne T. Management strategies for hyperemesis[J]. Best Praet lles Cliu Obstet Gynaecol, 2009, 23(4):549-564.
  • 9Di Gangi S, Gizzo S, Patrelli TS, et al. Wernieke' s eneephalopathy complicating hyperemesis gravidarum: from the background to the present[J]. J Maternal FetalNeonatal Med, 2012, 25(8):1499-1504.
  • 10Slaughter SR, Hearns-Stokes R, van der Vluqt T, et al. FDA approval of doxylamine-pyridoxine therapy for use in pregnancy[J]. N Engl J Med, 2014,307(12): 1081-1083.

共引文献146

同被引文献41

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部